Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 7, Pages 98-111
http://dx.doi.org/10.1100/tsw.2007.230
Mini-Review Article

Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward

1Department of Psychology and the Center for Neuroscience, University of Colorado at Boulder, Boulder, CO 80309-0345, USA
2Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia
3Avigen Inc., Alameda, CA, USA
4Chemical Biology Research Branch, National Institute on Drug Abuse, Bethesda, MD, USA

Received 20 June 2007; Revised 3 August 2007; Accepted 5 August 2007

Academic Editors: D. Shurtleff and S. Ferre

Copyright © 2007 Mark R. Hutchinson et al.

Citations to this Article [195 citations]

The following is the list of published articles that have cited the current article.

  • Hansson, Westerlund, Björklund, and Olsson, “μ-Opioid agonists inhibit the enhanced intracellular Ca2+ responses in inflammatory activated astrocytes co-cultured with brain endothelial cells,” Neuroscience, vol. 155, no. 4, pp. 1237–1249, 2008. View at Publisher · View at Google Scholar
  • Leslie J Crofford, “Pain management in fibromyalgia,” Current Opinion in Internal Medicine, vol. 7, no. 4, pp. 404–408, 2008. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Yingning Zhang, Kimberley Brown, Benjamen D. Coats, Mitesh Shridhar, Paige W. Sholar, Sonica J. Patel, Nicole Y. Crysdale, Jacqueline A. Harrison, Steven F. Maier, Kenner C. Rice, and Linda R. Watkins, “Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4),” European Journal of Neuroscience, vol. 28, no. 1, pp. 20–29, 2008. View at Publisher · View at Google Scholar
  • Milligan, Sloane, and Watkins, “Glia in pathological pain: A role for fractalkine,” Journal of Neuroimmunology, vol. 198, no. 1-2, pp. 113–120, 2008. View at Publisher · View at Google Scholar
  • E. D. Milligan, E. M. Sloane, and L. R. Watkins, “Glia in pathological pain: A role for fractalkine,” Journal Of Neuroimmunology, vol. 198, no. 1-2, pp. 113–120, 2008. View at Publisher · View at Google Scholar
  • Joel R. Saper, and Alvin E. Lake III, “Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: Limited efficacy, risks, and proposed guidelines,” Headache, vol. 48, no. 6, pp. 838–849, 2008. View at Publisher · View at Google Scholar
  • Leslie J. Crofford, “Pain management in fibromyalgia,” Current Opinion in Rheumatology, vol. 20, no. 3, pp. 246–250, 2008. View at Publisher · View at Google Scholar
  • Paul Rolan, Jacqueline A. Gibbons, Lin He, Eppie Chang, Drew Jones, Matthew I. Gross, Jennifer Bahr Davidson, Laura M. Sanftner, and Kirk W. Johnson, “Ibudilast in healthy volunteers: Safety, tolerability and pharmacokinetics with single and multiple doses,” British Journal of Clinical Pharmacology, vol. 66, no. 6, pp. 792–801, 2008. View at Publisher · View at Google Scholar
  • Ya Li, Anna R. Chase, Peter F. Slivka, Clyde T. Baggett, Tina X. Zhao, and Hang Yin, “Design, synthesis, and evaluation of biotinylated opioid derivatives as novel probes to study opioid pharmacology,” Bioconjugate Chemistry, vol. 19, no. 12, pp. 2585–2589, 2008. View at Publisher · View at Google Scholar
  • Leigh A. Lamont, “Multimodal Pain Management in Veterinary Medicine: The Physiologic Basis of Pharmacologic Therapies,” Veterinary Clinics of North America: Small Animal Practice, vol. 38, no. 6, pp. 1173–1186, 2008. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Benjamen D. Coats, Susannah S. Lewis, Yingning Zhang, David B. Sprunger, Niloofar Rezvani, Eric M. Baker, Brian M. Jekich, Julie L. Wieseler, Andrew A. Somogyi, David Martin, Stephen Poole, Charles M. Judd, Steven F. Maier, and Linda R. Watkins, “Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1178–1189, 2008. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Alexis L. Northcutt, Lindsey W. Chao, Jeffrey J. Kearney, Yingning Zhang, Debra L. Berkelhammer, Lisa C. Loram, Robert R. Rozeske, Sondra T. Bland, Steven F. Maier, Todd T. Gleeson, and Linda R. Watkins, “Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia,” Brain, Behavior, and Immunity, vol. 22, no. 8, pp. 1248–1256, 2008. View at Publisher · View at Google Scholar
  • Marte Handal, Åse Ripel, Svetlana Skurtveit, and Jørg Mørland, “Behavioural sensitization in mice induced by morphine-glucuronide metabolites,” Pharmacology Biochemistry and Behavior, vol. 90, no. 4, pp. 578–585, 2008. View at Publisher · View at Google Scholar
  • Jim Bartley, and Linda R. Watkins, “Comment on: Excessive opioid use and the development of chronic migraine,” Pain, vol. 145, no. 1-2, pp. 262–263, 2009. View at Publisher · View at Google Scholar
  • Howard S Smith, “Future of minimizing opioid adverse effects while maintaining or improving opioid-related analgesia,” Therapy, vol. 6, no. 5, pp. 667–683, 2009. View at Publisher · View at Google Scholar
  • Vigdis Vindenes, Åse Ripel, Marte Handal, Fernando Boix, and Jørg Mørland, “Interactions between morphine and the morphine-glucuronides measured by conditioned place preference and locomotor activity,” Pharmacology Biochemistry and Behavior, vol. 93, no. 1, pp. 1–9, 2009. View at Publisher · View at Google Scholar
  • Michelle A. Hook, Georgina Moreno, Sarah Woller, Denise Puga, Kevin Hoy Jr., Robyn Balden, and James W. Grau, “Intrathecal morphine attenuates recovery of function after a spinal cord injury,” Journal of Neurotrauma, vol. 26, no. 5, pp. 741–752, 2009. View at Publisher · View at Google Scholar
  • Sondra T. Bland, Mark R. Hutchinson, Steven F. Maier, Linda R. Watkins, and Kirk W. Johnson, “The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release,” Brain, Behavior, and Immunity, vol. 23, no. 4, pp. 492–497, 2009. View at Publisher · View at Google Scholar
  • Jim Bartley, “Could glial activation be a factor in migraine?,” Medical Hypotheses, vol. 72, no. 3, pp. 255–257, 2009. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Susannah S. Lewis, Benjamen D. Coats, David A. Skyba, Nicole Y. Crysdale, Debra L. Berkelhammer, Anita Brzeski, Alexis Northcutt, Christine M. Vietz, Charles M. Judd, Steven F. Maier, Linda R. Watkins, and Kirk W. Johnson, “Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast),” Brain, Behavior, and Immunity, vol. 23, no. 2, pp. 240–250, 2009. View at Publisher · View at Google Scholar
  • Jim Bartley, “Post herpetic neuralgia, schwann cell activation and vitamin D,” Medical Hypotheses, vol. 73, no. 6, pp. 927–929, 2009. View at Publisher · View at Google Scholar
  • M.R. Hutchinson, K.M. Ramos, L.C. Loram, J. Wieseler, P.W. Sholar, J.J. Kearney, M.T. Lewis, N.Y. Crysdale, Y. Zhang, J.A. Harrison, S.F. Maier, K.C. Rice, and L.R. Watkins, “Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats,” Neuroscience, vol. 164, no. 4, pp. 1821–1832, 2009. View at Publisher · View at Google Scholar
  • Rolan, Hutchinson, and Johnson, “Ibudilast: A review of its pharmacology, efficacy and safety in respiratory and neurological disease,” Expert Opinion on Pharmacotherapy, vol. 10, no. 17, pp. 2897–2904, 2009. View at Publisher · View at Google Scholar
  • Linda R. Watkins, Mark R. Hutchinson, Kenner C. Rice, and Steven F. Maier, “The "Toll" of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia,” Trends in Pharmacological Sciences, vol. 30, no. 11, pp. 581–591, 2009. View at Publisher · View at Google Scholar
  • Liang Liu, Mark R. Hutchinson, Jason M. White, Andrew A. Somogyi, and Janet K. Coller, “Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence,” Pharmacogenetics and Genomics, vol. 19, no. 11, pp. 869–876, 2009. View at Publisher · View at Google Scholar
  • Ilaria Ceccarelli, Antonella Rossi, Melinda Maddalena, Elisabetta Weber, and Anna Maria Aloisi, “Effects of morphine on testosterone levels in rat C6 glioma cells: Modulation by anastrozole,” Journal of Cellular Physiology, vol. 221, no. 1, pp. 1–4, 2009. View at Publisher · View at Google Scholar
  • Miroslav Misha Backonja, “The role of opioid therapy in the treatment of neuropathic pain,” CONTINUUM Lifelong Learning in Neurology, vol. 15, no. 5, pp. 84–100, 2009. View at Publisher · View at Google Scholar
  • Erin D. Milligan, and Linda R. Watkins, “Pathological and protective roles of glia in chronic pain,” Nature Reviews Neuroscience, vol. 10, no. 1, pp. 23–36, 2009. View at Publisher · View at Google Scholar
  • Jessica K. Alexander, and Phillip G. Popovich, “Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration,” Neurotherapy: Progress in Restorative Neuroscience and Neurology, vol. 175, pp. 125–137, 2009. View at Publisher · View at Google Scholar
  • B. David Westin, Suellen M. Walker, Ronald Deumens, Marjorie Grafe, and Tony L. Yaksh, “Validation of a preclinical spinal safety model: Effects of intrathecal morphine in the neonatal rat,” Anesthesiology, vol. 113, no. 1, pp. 183–199, 2010. View at Publisher · View at Google Scholar
  • Madison M. Buchanan, Mark Hutchinson, Linda R. Watkins, and Hang Yin, “Toll-like receptor 4 in CNS pathologies,” Journal of Neurochemistry, vol. 114, no. 1, pp. 13–27, 2010. View at Publisher · View at Google Scholar
  • Joel R. Saper, Alvin E. Lake III, Philip A. Bain, Mark J. Stillman, John F. Rothrock, Ninan T. Mathew, Robert L. Hamel, Maureen Moriarty, and Gretchen E. Tietjen, “A practice guide for continuous opioid therapy for refractory daily headache: Patient selection, physician requirements, and treatment monitoring,” Headache, vol. 50, no. 7, pp. 1175–1193, 2010. View at Publisher · View at Google Scholar
  • Patrick M. Beardsley, Keith L. Shelton, Elizabeth Hendrick, and Kirk W. Johnson, “The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse,” European Journal of Pharmacology, vol. 637, no. 1-3, pp. 102–108, 2010. View at Publisher · View at Google Scholar
  • Peggy Compton, Priscilla Kehoe, Karabi Sinha, Matt A. Torrington, and Walter Ling, “Gabapentin improves cold-pressor pain responses in methadone-maintained patients,” Drug and Alcohol Dependence, vol. 109, no. 1-3, pp. 213–219, 2010. View at Publisher · View at Google Scholar
  • Beth D. Darnall, Mikel Aickin, and Heather Zwickey, “Pilot study of inflammatory responses following a negative imaginal focus in persons with chronic pain: Analysis by sex/gender,” Gender Medicine, vol. 7, no. 3, pp. 247–260, 2010. View at Publisher · View at Google Scholar
  • M.R. Hutchinson, L.C. Loram, Y. Zhang, M. Shridhar, N. Rezvani, D. Berkelhammer, S. Phipps, P.S. Foster, K. Landgraf, J.J. Falke, K.C. Rice, S.F. Maier, H. Yin, and L.R. Watkins, “Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity,” Neuroscience, vol. 168, no. 2, pp. 551–563, 2010. View at Publisher · View at Google Scholar
  • M.R. Hutchinson, S.S. Lewis, B.D. Coats, N. Rezvani, Y. Zhang, J.L. Wieseler, A.A. Somogyi, H. Yin, S.F. Maier, K.C. Rice, and L.R. Watkins, “Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences,” Neuroscience, vol. 167, no. 3, pp. 880–893, 2010. View at Publisher · View at Google Scholar
  • Sondra T. Bland, Jacob T. Beckley, Linda R. Watkins, Steven F. Maier, and Staci D. Bilbo, “Neonatal Escherichia coli infection alters glial, cytokine, and neuronal gene expression in response to acute amphetamine in adolescent rats,” Neuroscience Letters, vol. 474, no. 1, pp. 52–57, 2010. View at Publisher · View at Google Scholar
  • Haroon Hameed, Mariam Hameed, and Paul J. Christo, “The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs,” Current Pain and Headache Reports, vol. 14, no. 2, pp. 96–104, 2010. View at Publisher · View at Google Scholar
  • Theresa-Alexandra M. Mattioli, Brian Milne, and Catherine M. Cahill, “Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats,” Molecular Pain, vol. 6, 2010. View at Publisher · View at Google Scholar
  • Julie Desroches, and Pierre Beaulieu, “Opioids and cannabinoids interactions: Involvement in pain management,” Current Drug Targets, vol. 11, no. 4, pp. 462–473, 2010. View at Publisher · View at Google Scholar
  • Albert Stuart Reece, “Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing,” Medical Hypotheses, vol. 75, no. 6, pp. 613–619, 2010. View at Publisher · View at Google Scholar
  • Benito, Aguado, Abreu, García-Fernández, and Gómez De Segura, “Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat,” British Journal of Anaesthesia, vol. 105, no. 6, pp. 810–817, 2010. View at Publisher · View at Google Scholar
  • Albert Dahan, Leon Aarts, and Terry W. Smith, “Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression,” Anesthesiology, vol. 112, no. 1, pp. 226–238, 2010. View at Publisher · View at Google Scholar
  • Robin Slover, Gail L. Neuenkirchen, Sola Olamikan, and Sheryl Kent, “Chronic Pediatric Pain,” Advances in Pediatrics, vol. 57, no. 1, pp. 141–162, 2010. View at Publisher · View at Google Scholar
  • Adam J. Carinci, and Jianren Mao, “Pain and Opioid Addiction: What is the Connection?,” Current Pain and Headache Reports, vol. 14, no. 1, pp. 17–21, 2010. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Yingning Zhang, Mitesh Shridhar, John H. Evans, Madison M. Buchanan, Tina X. Zhao, Peter F. Slivka, Benjamen D. Coats, Niloofar Rezvani, Julie Wieseler, Travis S. Hughes, Kyle E. Landgraf, Stefanie Chan, Stephanie Fong, Simon Phipps, Joseph J. Falke, Leslie A. Leinwand, Steven F. Maier, Hang Yin, Kenner C. Rice, and Linda R. Watkins, “Evidence that opioids may have toll-like receptor 4 and MD-2 effects,” Brain, Behavior, and Immunity, vol. 24, no. 1, pp. 83–95, 2010. View at Publisher · View at Google Scholar
  • Lindsay H. Burns, and Hoau-Yan Wang, “Ultra-low-dose naloxone or naltrexone to improve opioid analgesia: The history, the mystery and a novel approach,” Clinical Medicine Insights: Therapeutics, vol. 2, pp. 857–868, 2010. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, Yehuda Shavit, Peter M. Grace, Kenner C. Rice, Steven F. Maier, and Linda R. Watkins, “Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia,” Pharmacological Reviews, vol. 63, no. 3, pp. 772–810, 2011. View at Publisher · View at Google Scholar
  • Liang Liu, Janet K. Coller, Linda R. Watkins, Andrew A. Somogyi, and Mark R. Hutchinson, “Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains,” Brain, Behavior, and Immunity, vol. 25, no. 6, pp. 1223–1232, 2011. View at Publisher · View at Google Scholar
  • Matthew G. Frank, Linda R. Watkins, and Steven F. Maier, “Stress- and glucocorticoid-induced priming of neuroinflammatory responses: Potential mechanisms of stress-induced vulnerability to drugs of abuse,” Brain, Behavior, and Immunity, vol. 25, no. 1, pp. S21–S28, 2011. View at Publisher · View at Google Scholar
  • Yue Wu, Erin L. Lousberg, Lachlan M. Moldenhauer, John D. Hayball, Sarah A. Robertson, Janet K. Coller, Linda R. Watkins, Andrew A. Somogyi, and Mark R. Hutchinson, “Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment,” Brain, Behavior, and Immunity, vol. 25, no. 1, pp. S155–S164, 2011. View at Publisher · View at Google Scholar
  • Robert B. Raffa, and Joseph V. Pergolizzi, “Opioid-Induced Hyperalgesia: Is It Clinically Relevant for the Treatment of Pain Patients?,” Pain Management Nursing, 2011. View at Publisher · View at Google Scholar
  • J Sun, S Liu, M Mata, D J Fink, and S Hao, “Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats,” Gene Therapy, vol. 19, no. 1, pp. 101–108, 2011. View at Publisher · View at Google Scholar
  • Serena Stopponi, Lorenzo Somaini, Andrea Cippitelli, Nazzareno Cannella, Simone Braconi, Marsida Kallupi, Barbara Ruggeri, Markus Heilig, Gregory Demopulos, George Gaitanaris, Maurizio Massi, and Roberto Ciccocioppo, “Activation of Nuclear PPARγ Receptors by the Antidiabetic Agent Pioglitazone Suppresses Alcohol Drinking and Relapse to Alcohol Seeking,” Biological Psychiatry, vol. 69, no. 7, pp. 642–649, 2011. View at Publisher · View at Google Scholar
  • Ana Campillo, David Cabañero, Asunción Romero, Paula García-Nogales, and Margarita María Puig, “Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice,” European Journal of Pharmacology, vol. 657, no. 1-3, pp. 89–96, 2011. View at Publisher · View at Google Scholar
  • S. Raghavan, A.D. Harvey, and S.R. Humble, “New opioid side effects and implications for long-term therapy,” Trends in Anaesthesia and Critical Care, vol. 1, no. 1, pp. 18–21, 2011. View at Publisher · View at Google Scholar
  • Yi Zhang, Hui Li, Yi Li, Xiuli Sun, Mengyang Zhu, Gregory Hanley, Gene LeSage, and Deling Yin, “Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice,” Neuroscience Letters, vol. 489, no. 1, pp. 43–47, 2011. View at Publisher · View at Google Scholar
  • Jianren Mao, Michael S. Gold, and Miroslav Backonja, “Combination drug therapy for chronic pain: A call for more clinical studies,” Journal of Pain, vol. 12, no. 2, pp. 157–166, 2011. View at Publisher · View at Google Scholar
  • Michelle A. Hook, Stephanie N. Washburn, Georgina Moreno, Sarah A. Woller, Denise Puga, Kuan H. Lee, and James W. Grau, “An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury,” Brain, Behavior, and Immunity, vol. 25, no. 2, pp. 349–359, 2011. View at Publisher · View at Google Scholar
  • Shuanglin Hao, Shue Liu, Xuexing Zheng, Wenwen Zheng, Handong Ouyang, Marina Mata, and David J. Fink, “The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats,” Neuropsychopharmacology, vol. 36, no. 3, pp. 664–676, 2011. View at Publisher · View at Google Scholar
  • Beth Darnall, and Hong Li, “Hysterectomy and Predictors for Opioid Prescription in a Chronic Pain Clinic Sample,” Pain Medicine, vol. 12, no. 2, pp. 196–203, 2011. View at Publisher · View at Google Scholar
  • Karsten Ahlbeck, “Opioids: A two-faced Janus,” Current Medical Research and Opinion, vol. 27, no. 2, pp. 439–448, 2011. View at Publisher · View at Google Scholar
  • Chris Hayes, and Fiona J. Hodson, “A Whole-Person Model of Care for Persistent Pain: From Conceptual Framework to Practical Application,” Pain Medicine, vol. 12, no. 12, pp. 1738–1749, 2011. View at Publisher · View at Google Scholar
  • Ruben Vardanyan, Vlad K. Kumirov, and Victor J. Hruby, “Improved synthesis of d,l-fluorocitric acid,” Journal of Fluorine Chemistry, vol. 132, no. 11, pp. 920–924, 2011. View at Publisher · View at Google Scholar
  • Jamil Ahsan Kazi, and Mohamed Ibrahim Abu-Hassan, “Gabapentin completely attenuated the acute morphine-induced c-Fos expression in the rat nucleus accumbens,” Journal of Molecular Neuroscience, vol. 45, no. 2, pp. 101–109, 2011. View at Publisher · View at Google Scholar
  • Charles Argoff, “Mechanisms of pain transmission and pharmacologic management,” Current Medical Research and Opinion, vol. 27, no. 10, pp. 2019–2031, 2011. View at Publisher · View at Google Scholar
  • Greg A. Weir, and M Zameel Cader, “New directions in migraine,” BMC Medicine, vol. 9, 2011. View at Publisher · View at Google Scholar
  • Jaclyn M. Schwarz, and Staci D. Bilbo, “The Immune System and the Developing Brain,” Colloquium Series on The Developing Brain, vol. 2, no. 3, pp. 1–128, 2011. View at Publisher · View at Google Scholar
  • Jonathan P. Wisor, William C. Clegern, and Michelle A. Schmidt, “Toll-like receptor 4 is a regulator of monocyte and electroencephalographic responses to sleep loss,” Sleep, vol. 34, no. 10, pp. 1335–1345, 2011. View at Publisher · View at Google Scholar
  • Nazira El-Hage, Elizabeth M. Podhaizer, Jamie Sturgill, and Kurt F. Hauser, “Toll-like Receptor Expression and Activation in Astroglia: Differential Regulation by HIV-1 Tat, gp120, and Morphine,” Immunological Investigations, vol. 40, no. 5, pp. 498–522, 2011. View at Publisher · View at Google Scholar
  • Albert Stuart Reece, “Hypothalamic opioid-Melanocortin appetitive balance and addictive craving,” Medical Hypotheses, vol. 76, no. 1, pp. 132–137, 2011. View at Publisher · View at Google Scholar
  • Shaifali Bhalla, Vaide Rapolaviciute, and Anil Gulati, “Determination of α2-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874,” European Journal of Pharmacology, vol. 651, no. 1-3, pp. 109–121, 2011. View at Publisher · View at Google Scholar
  • D. Fletcher, “Farmacologia degli oppioidi,” EMC - Anestesia-Rianimazione, vol. 16, no. 2, pp. 1–22, 2011. View at Publisher · View at Google Scholar
  • D. Fletcher, “Pharmacologie des opioïdes,” EMC - Anesthésie-Réanimation, vol. 8, no. 1, pp. 1–22, 2011. View at Publisher · View at Google Scholar
  • D. Fletcher, “Farmacología de los opioides,” EMC - Anestesia-Reanimación, vol. 37, no. 2, pp. 1–24, 2011. View at Publisher · View at Google Scholar
  • Farzaneh Rostami, Shahrbanoo Oryan, Abolhassan Ahmadiani, and Leila Dargahi, “Morphine Preconditioning Protects Against LPS-Induced Neuroinflammation and Memory Deficit,” Journal of Molecular Neuroscience, vol. 48, no. 1, pp. 22–34, 2012. View at Publisher · View at Google Scholar
  • Christopher Hayes, Richard Naylor, and Garry Egger, “Understanding Chronic Pain in a Lifestyle Context: The Emergence of a Whole-Person Approach,” American Journal of Lifestyle Medicine, vol. 6, no. 5, pp. 421–428, 2012. View at Publisher · View at Google Scholar
  • Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, and John T. Sinnott, “Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse,” Molecular Diagnosis & Therapy, vol. 13, no. 3, pp. 153–179, 2012. View at Publisher · View at Google Scholar
  • Jun Shen, Lyle E. Fox, and Jianguo Cheng, “Differential Effects of Peripheral versus Central Coadministration of QX-314 and Capsaicin on Neuropathic Pain in Rats,” Anesthesiology, vol. 117, no. 2, pp. 365–380, 2012. View at Publisher · View at Google Scholar
  • Antonio Gatti, Marzia Lazzari, Valentina Gianfelice, Annarita Di Paolo, Elisabetta Sabato, and Alessandro Fabrizio Sabato, “Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis,” Pain Medicine, vol. 13, no. 9, pp. 1121–1130, 2012. View at Publisher · View at Google Scholar
  • Janet K. Coller, and Mark R. Hutchinson, “Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence,” Pharmacology & Therapeutics, vol. 134, no. 2, pp. 219–245, 2012. View at Publisher · View at Google Scholar
  • C.-Y. Chiang, B. J. Sessle, and J. O. Dostrovsky, “Role of Astrocytes in Pain,” Neurochemical Research, vol. 37, no. 11, pp. 2419–2431, 2012. View at Publisher · View at Google Scholar
  • Lauren Nicotra, Lisa C. Loram, Linda R. Watkins, and Mark R. Hutchinson, “Toll-like receptors in chronic pain,” Experimental Neurology, vol. 234, no. 2, pp. 316–329, 2012. View at Publisher · View at Google Scholar
  • X. Wang, L. C. Loram, K. Ramos, A. J. de Jesus, J. Thomas, K. Cheng, A. Reddy, A. A. Somogyi, M. R. Hutchinson, L. R. Watkins, and H. Yin, “Morphine activates neuroinflammation in a manner parallel to endotoxin,” Proceedings of the National Academy of Sciences, vol. 109, no. 16, pp. 6325–6330, 2012. View at Publisher · View at Google Scholar
  • Suneeta Tumati, Tally M. Largent-Milnes, Attila Keresztes, Jiyang Ren, William R. Roeske, Todd W. Vanderah, and Eva V. Varga, “Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist,” Journal of Neuroimmunology, vol. 244, no. 1-2, pp. 23–31, 2012. View at Publisher · View at Google Scholar
  • Xue-Qin Zhang, Yu Cui, Yue Cui, Yu Chen, Xiao-Dong Na, Feng-Ying Chen, Xu-Hong Wei, Yong-Yong Li, Xian-Guo Liu, and Wen-Jun Xin, “Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference,” Brain, Behavior, and Immunity, vol. 26, no. 2, pp. 318–325, 2012. View at Publisher · View at Google Scholar
  • Ziva D Cooper, Jermaine D Jones, and Sandra D Comer, “Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances,” Expert Opinion on Investigational Drugs, vol. 21, no. 2, pp. 169–178, 2012. View at Publisher · View at Google Scholar
  • Qingshan Wang, Hui Zhou, Huiming Gao, Shih-Heng Chen, Chun-Hsien Chu, Belinda Wilson, and Jau-Shyong Hong, “Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase,” Journal of Neuroinflammation, vol. 9, 2012. View at Publisher · View at Google Scholar
  • Qian Li, “Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance,” Medical Hypotheses, vol. 79, no. 6, pp. 754–756, 2012. View at Publisher · View at Google Scholar
  • Lisa C. Loram, Peter M. Grace, Keith A. Strand, Frederick R. Taylor, Amanda Ellis, Debra Berkelhammer, Melissa Bowlin, Bryce Skarda, Steven F. Maier, and Linda R. Watkins, “Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy,” Brain, Behavior, and Immunity, vol. 26, no. 8, pp. 1256–1264, 2012. View at Publisher · View at Google Scholar
  • Chris Hayes, Meredith S. Jordan, Fiona J. Hodson, and Linda Ritchard, “Ceasing Intrathecal Therapy in Chronic Non-Cancer Pain: An Invitation to Shift from Biomedical Focus to Active Management,” Plos One, vol. 7, no. 11, 2012. View at Publisher · View at Google Scholar
  • Yan-Hua Li, Hua Jin, Jing-Shu Xu, Guang-Qiong Guo, Da-Lin Chen, and Yun Bo, “Complement factor C5a and C5a receptor contribute to morphine tolerance and withdrawal-induced hyperalgesia in rats,” Experimental and Therapeutic Medicine, vol. 4, no. 4, pp. 723–727, 2012. View at Publisher · View at Google Scholar
  • Belén Gago, Kjell Fuxe, Stefan Brené, Zaida Díaz-Cabiale, María Dolores Reina-Sánchez, Diana Suárez-Boomgaard, Ruth Roales-Buján, Alejandra Valderrama-Carvajal, Adelaida de la Calle, and Alicia Rivera, “ Early modulation by the dopamine D 4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen ,” Journal of Neuroscience Research, 2013. View at Publisher · View at Google Scholar
  • Anna Rita Togna, Letizia Antonilli, Melania Dovizio, Adele Salemme, Lorenza De Carolis, Giuseppina I. Togna, Paola Patrignani, and Paolo Nencini, “In vitro morphine metabolism by rat microglia,” Neuropharmacology, 2013. View at Publisher · View at Google Scholar
  • Mark R. Hutchinson, and Linda R. Watkins, “Why is Neuroimmunopharmacology crucial for the future of addiction research?,” Neuropharmacology, 2013. View at Publisher · View at Google Scholar
  • Dusica Bajic, Kathryn G. Commons, and Sulpicio G. Soriano, “Morphine-enhanced apoptosis in selective brain regions of neonatal rats,” International Journal of Developmental Neuroscience, vol. 31, no. 4, pp. 258–266, 2013. View at Publisher · View at Google Scholar
  • Javier Benito, Javier Garcia-Fernandez, Ignacio A. Gómez de Segura, Delia Aguado, and Mariana Abreu, “Effects of Naloxone on Opioid-induced Hyperalgesia and Tolerance to Remifentanil under Sevoflurane Anesthesia in Rats,” Anesthesiology, vol. 118, no. 5, pp. 1160–1169, 2013. View at Publisher · View at Google Scholar
  • Marc De Kock, Sebastien Loix, and Patricia Lavand'homme, “Ketamine and Peripheral Inflammation,” CNS Neuroscience & Therapeutics, vol. 19, no. 6, pp. 403–410, 2013. View at Publisher · View at Google Scholar
  • Robert Taylor, Joseph V Pergolizzi, Frank Porreca, and Robert B Raffa, “Opioid antagonists for pain,” Expert Opinion on Investigational Drugs, vol. 22, no. 4, pp. 517–525, 2013. View at Publisher · View at Google Scholar
  • Sarah A. Woller, and Michelle A. Hook, “Opioid administration following spinal cord injury: Implications for pain and locomotor recovery,” Experimental Neurology, 2013. View at Publisher · View at Google Scholar
  • Cw Stevens, S Aravind, S Das, and Rl Davis, “Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4,” British Journal of Pharmacology, vol. 168, no. 6, pp. 1421–1429, 2013. View at Publisher · View at Google Scholar
  • Charles H. Knowles, Greger Lindberg, Emanuele Panza, and Roberto De Giorgio, “New perspectives in the diagnosis and management of enteric neuropathies,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 4, pp. 206–218, 2013. View at Publisher · View at Google Scholar
  • Chih-Ping Yang, Chen-Hwan Cherng, Ching-Tang Wu, Hui-Yi Huang, Pao-Luh Tao, Sing-Ong Lee, and Chih-Shung Wong, “Intrathecal Ultra-Low Dose Naloxone Enhances the Antihyperalgesic Effects of Morphine and Attenuates Tumor Necrosis Factor-α and Tumor Necrosis Factor-α Receptor 1 Expression in the Dorsal Horn of Rats with Partial Sciatic Nerve Transection,” Anesthesia & Analgesia, vol. 117, no. 6, pp. 1493–1502, 2013. View at Publisher · View at Google Scholar
  • Devki D. Sukhtankar, Heeseung Lee, Kenner C. Rice, and Mei-Chuan Ko, “Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain,” Psychopharmacology, 2013. View at Publisher · View at Google Scholar
  • Jacinta L. Johnson, Mark R. Hutchinson, Desmond B. Williams, and Paul Rolan, “Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment,” Cephalalgia, vol. 33, no. 1, pp. 52–64, 2013. View at Publisher · View at Google Scholar
  • Anne Z. Murphy, and Lori N. Eidson, “Blockade of Toll-Like Receptor 4 Attenuates Morphine Tolerance and Facilitates the Pain Relieving Properties of Morphine,” Journal Of Neuroscience, vol. 33, no. 40, pp. 15952–15963, 2013. View at Publisher · View at Google Scholar
  • Ashish K. Rehni, Amteshwar S. Jaggi, and Nirmal Singh, “Opioid withdrawal syndrome: Emerging concepts and novel therapeutic targets,” CNS and Neurological Disorders - Drug Targets, vol. 12, no. 1, pp. 112–125, 2013. View at Publisher · View at Google Scholar
  • Xiaohui Wang, Christina Smith, and Hang Yin, “Targeting Toll-like receptors with small molecule agents,” Chemical Society Reviews, vol. 42, no. 12, pp. 4859, 2013. View at Publisher · View at Google Scholar
  • John L. Clifford, Marcie Fowler, Jacob J. Hansen, Bopiah Cheppudira, Jennifer E. Nyland, Margaux M. Salas, Laura L. McGhee, Lawrence N. Petz, and Dayna R. Loyd, “State of the science review,” Journal of Trauma and Acute Care Surgery, vol. 77, pp. S228–S236, 2014. View at Publisher · View at Google Scholar
  • Eva Szigethy, Marc Schwartz, and Douglas Drossman, “Narcotic Bowel Syndrome and Opioid-Induced Constipation,” Current Gastroenterology Reports, vol. 16, no. 10, 2014. View at Publisher · View at Google Scholar
  • James W. Grau, J. Russell Huie, Kuan H. Lee, Kevin C. Hoy, Yung-Jen Huang, Joel D. Turtle, Misty M. Strain, Kyle M. Baumbauer, Rajesh M. Miranda, Michelle A. Hook, Adam R. Ferguson, and Sandra M. Garraway, “Metaplasticity and behavior: how training and inflammation affect plastic potential within the spinal cord and recovery after injury,” Frontiers in Neural Circuits, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Hao Xu, Tao Xu, Xia-Qing Ma, and Wei Jiang, “Chronic morphine treatment increased the expression of myeloid differentiation primary response protein 88 in rat spinal cord,” Journal of Integrative Neuroscience, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Hamed Ghavimi, Mohammad Charkhpour, Saeed Ghasemi, Mehran Mesgari, Hadi Hamishehkare, Katayoun Hassanzadeh, Sanam Arami, and Kambiz Hassanzadeh, “Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex,” Pharmacological Reports, 2014. View at Publisher · View at Google Scholar
  • Andrew Schrepf, Michael O’Donnell, Yi Luo, Catherine S. Bradley, Karl Kreder, and Susan Lutgendorf, “Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms,” Pain®, 2014. View at Publisher · View at Google Scholar
  • Hamed Ghavimi, Kambiz Hassanzadeh, Nasrin Maleki-Dizaji, Alireza Azarfardian, Saeed Ghasami, Elmira Zolali, and Mohammad Charkhpour, “Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats,” Naunyn-Schmiedeberg's Archives of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Michal Bajo, Samuel G. Madamba, Marisa Roberto, and George R. Siggins, “Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP,” Frontiers in Integrative Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Theresa Alexandra Mattioli, Heather Leduc-Pessah, Graham Skelhorne-Gross, Chris J. B. Nicol, Brian Milne, Tuan Trang, and Catherine M. Cahill, “Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Jacob E. Kurlander, and Douglas A. Drossman, “Diagnosis and treatment of narcotic bowel syndrome,” Nature Reviews Gastroenterology & Hepatology, 2014. View at Publisher · View at Google Scholar
  • Daniel J. Chew, Thomas Carlstedt, and Peter J. Shortland, “The effects of minocycline or riluzole treatment on spinal root avulsion-induced pain in adult rats,” The Journal of Pain, 2014. View at Publisher · View at Google Scholar
  • Peter M. Grace, Mark R. Hutchinson, Steven F. Maier, and Linda R. Watkins, “Pathological pain and the neuroimmune interface,” Nature Reviews Immunology, 2014. View at Publisher · View at Google Scholar
  • Giordano de Guglielmo, Marsida Kallupi, Giulia Scuppa, Serena Stopponi, Gregory Demopulos, George Gaitanaris, and Roberto Ciccocioppo, “Analgesic tolerance to morphine is regulated by PPAR gamma,” British Journal of Pharmacology, vol. 171, no. 23, pp. 5407–5416, 2014. View at Publisher · View at Google Scholar
  • Stephen G. Henry, Barth L. Wilsey, Joy Melnikow, and Ana-Maria Iosif, “Dose Escalation During the First Year of Long-Term Opioid Therapy for Chronic Pain,” Pain Medicine, 2014. View at Publisher · View at Google Scholar
  • Hannah R. Wardill, Ysabella Z.A. Van Sebille, Kimberley A. Mander, Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, and Stephen T. Sonis, “Toll-Like receptor 4 signaling: a common biological mechanism of regimen-related toxicities An emerging hypothesis for neuropathy and gastrointestinal toxicity,” Cancer Treatment Reviews, 2014. View at Publisher · View at Google Scholar
  • Liying Bai, Caihong Zhai, Kun Han, Zhisong Li, Junliang Qian, Ying Jing, Wei Zhang, and Ji-Tian Xu, “Toll-like receptor 4-mediated nuclear factor-κB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats,” Neuroscience Bulletin, vol. 30, no. 6, pp. 936–948, 2014. View at Publisher · View at Google Scholar
  • A.J. Kwilasz, P.M. Grace, P. Serbedzija, S.F. Maier, and L.R. Watkins, “The therapeutic potential of interleukin-10 in neuroimmune diseases,” Neuropharmacology, 2014. View at Publisher · View at Google Scholar
  • J L Johnson, P E Rolan, M E Johnson, L Bobrovskaya, D B Williams, K Johnson, J Tuke, and M R Hutchinson, “Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation,” Translational Psychiatry, vol. 4, no. 11, pp. e482, 2014. View at Publisher · View at Google Scholar
  • Stuart Cathcart, Nicola Galatis, Maarten Immink, Michael Proeve, and John Petkov, “Brief Mindfulness-Based Therapy for Chronic Tension-Type Headache: A Randomized Controlled Pilot Study,” Behavioural and Cognitive Psychotherapy, vol. 42, no. 1, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • J. Mantz, M. -P. Dilly, and S. Sigaut, “Delirium en réanimation chez l’adulte: le choix des molécules a-t-il un rôle ?,” Réanimation, vol. 23, no. S2, pp. 372–378, 2014. View at Publisher · View at Google Scholar
  • Jonathan Henry W. Jacobsen, Linda R. Watkins, and Mark R. Hutchinson, “Discovery of a Novel Site of Opioid Action at the Innate Immune Pattern-Recognition Receptor TLR4 and its Role in Addiction,” Neuroimmune Signaling in Drug Actions and Addictions, vol. 118, pp. 129–163, 2014. View at Publisher · View at Google Scholar
  • Jacinta L. Johnson, Yuen H. Kwok, Nicole M. Sumracki, James E. Swift, Mark R. Hutchinson, Kirk Johnson, Desmond B. Williams, Jonathon Tuke, and Paul E. Rolan, “Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety,” Headache: The Journal of Head and Face Pain, 2015. View at Publisher · View at Google Scholar
  • Caroline A. Arout, Ellen Edens, Ismene L. Petrakis, and Mehmet Sofuoglu, “Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations,” CNS Drugs, 2015. View at Publisher · View at Google Scholar
  • Kim M. Lee, Kevin B. Chiu, Peter J. Didier, Kate C. Baker, and Andrew G. MacLean, “Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques,” Brain, Behavior, and Immunity, 2015. View at Publisher · View at Google Scholar
  • Jing Li, Adam Csakai, Jialin Jin, Fengchun Zhang, and Hang Yin, “Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation,” ChemMedChem, 2015. View at Publisher · View at Google Scholar
  • Alireza Shafie, Farshid Moradi, Esmael Izadpanah, Aram Mokarizadeh, Mohammad Raman Moloudi, Mehrnoush Nikzaban, and Kambiz Hassanzadeh, “Neuroprotection of donepezil against morphine-induced apoptosis Is mediated through toll-like receptors,” European Journal of Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Katharina J. Gerhold, Ruth Drdla-Schutting, Silke D. Honsek, Liesbeth Forsthuber, and Juergen Sandkuehler, “Pronociceptive and Antinociceptive Effects of Buprenorphine in the Spinal Cord Dorsal Horn Cover a Dose Range of Four Orders of Magnitude,” Journal Of Neuroscience, vol. 35, no. 26, pp. 9580–9594, 2015. View at Publisher · View at Google Scholar
  • Brandon R. Selfridge, Xiaohui Wang, Yingning Zhang, Hang Yin, Peter M. Grace, Linda R. Watkins, Arthur E. Jacobson, and Kenner C. Rice, “Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists,” Journal of Medicinal Chemistry, pp. 150605073830002, 2015. View at Publisher · View at Google Scholar
  • John L. Shannonhouse, Danielle M. Grater, Daniel York, Paul J. Wellman, and Caurnel Morgan, “Sex Differences in Motivational Responses to Dietary Fat in Syrian Hamsters,” Physiology & Behavior, 2015. View at Publisher · View at Google Scholar
  • Peter M. Grace, Steven F. Maier, and Linda R. Watkins, “Opioid-Induced Central Immune Signaling: Implications for Opioid Analgesia,” Headache: The Journal of Head and Face Pain, 2015. View at Publisher · View at Google Scholar
  • J. F. Peppin, and R. B. Raffa, “Delta opioid agonists: a concise update on potential therapeutic applications,” Journal of Clinical Pharmacy and Therapeutics, vol. 40, no. 2, pp. 155–166, 2015. View at Publisher · View at Google Scholar
  • Rachel D. Moloney, Siobhain M. O’Mahony, Timothy G. Dinan, and John F. Cryan, “Stress-Induced Visceral Pain: Toward Animal Models of Irritable-Bowel Syndrome and Associated Comorbidities,” Frontiers in Psychiatry, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Shuwei Qiu, Yimin Feng, Gene LeSage, Ying Zhang, Charles Stuart, Lei He, Yi Li, Yi Caudle, Ying Peng, and Deling Yin, “Chronic Morphine-Induced MicroRNA-124 Promotes Microglial Immunosuppression by Modulating P65 and TRAF6,” Journal Of Immunology, vol. 194, no. 3, pp. 1021–1030, 2015. View at Publisher · View at Google Scholar
  • Manoranjan S. D'Souza, “Glutamatergic transmission in drug reward: implications for drug addiction,” Frontiers in Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Jermaine D. Jones, Maria A. Sullivan, Jeanne M. Manubay, Shanthi Mogali, Verena E. Metz, Roberto Ciccocioppo, and Sandra D. Comer, “The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users,” Physiology & Behavior, 2015. View at Publisher · View at Google Scholar
  • Martin P. Helley, Wondwossen Abate, Jon H. Bennett, and Stephen W.N. Thompson, “The expression of Toll-like receptor 4, 7 and co-receptors in neurochemical sub-populations of rat trigeminal ganglion sensory neurons,” Neuroscience, 2015. View at Publisher · View at Google Scholar
  • Kelle M. Franklin, Sheketha R. Hauser, Amy W. Lasek, Jeanette McClintick, Zheng-Ming Ding, William J. McBride, and Richard L. Bell, “Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4),” Psychopharmacology, 2015. View at Publisher · View at Google Scholar
  • Vaskar Das, “An Introduction to Pain Pathways and Pain “Targets”,” 2015. View at Publisher · View at Google Scholar
  • Jan Honegr, Ondrej Soukup, Rafael Dolezal, David Malinak, Marek Penhaker, Roman Prymula, and Kamil Kuca, “Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists,” Current Medicinal Chemistry, vol. 22, no. 29, pp. 3306–3325, 2015. View at Publisher · View at Google Scholar
  • Hyemin Kim, Seyeon Bae, Kil-Young Kwon, Young-il Hwang, Jae Seung Kang, and Wang Jae Lee, “A combinational effect of acetaminophen and oriental herbs on the regulation of inflammatory mediators in microglia cell line, BV2,” Anatomy & Cell Biology, vol. 48, no. 4, pp. 244, 2015. View at Publisher · View at Google Scholar
  • Steven Ganzberg, “The Opioid Challenge,” Anesthesia Progress, vol. 63, no. 3, pp. 113–115, 2016. View at Publisher · View at Google Scholar
  • Ruth Elwood Martin, Jonathan Berkowitz, Evan Wood, Ryan McNeil, Milloy, Launette Marie Rieb, and Wendy V. Norman, “Withdrawal-associated injury site pain (WISP): A descriptive case series of an opioid cessation phenomenon,” Pain, vol. 157, no. 12, pp. 2865–2874, 2016. View at Publisher · View at Google Scholar
  • Lori N Eidson, Kiyoshi Inoue, Larry J Young, Malu G Tansey, and Anne Z Murphy, “Toll-like Receptor 4 Mediates Morphine-Induced Neuroinflammation and Tolerance via Soluble Tumor Necrosis Factor Signaling,” Neuropsychopharmacology, 2016. View at Publisher · View at Google Scholar
  • Kambiz Hassanzadeh, Bashir Khodadadi, Mohammad Raman Moloudi, Hassan Amini, Mohammad Reza Rahmani, and Esmael Izadpanah, “A new pharmacological role for thalidomide: Attenuation of morphine-induced tolerance in rats,” Acta Anaesthesiologica Taiwanica, 2016. View at Publisher · View at Google Scholar
  • Reza Arezoomandan, Marzieh Moradi, Ghassem Attarzadeh-Yazdi, Carlos Tomaz, and Abbas Haghparast, “Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference,” Brain Research Bulletin, 2016. View at Publisher · View at Google Scholar
  • Heather C. Brenhouse, and Jaclyn M. Schwarz, “Immunoadolescence: Neuroimmune development and adolescent behavior,” Neuroscience & Biobehavioral Reviews, 2016. View at Publisher · View at Google Scholar
  • Young Sung Kim, Woon Young Kim, Yeon-hwa Kim, Ji Won Yoo, and Too Jae Min, “The protective effect of hydromorphone to ischemia in rat glial cells,” SpringerPlus, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Bihel Frédéric, “Opioid adjuvant strategy: improving opioid effectiveness,” Future Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Gisele Ferreira Amaral, Pietro Domingues Dossa, Lígia Bocamino Viebig, Fabiana Toshie Camargo Konno, Amanda Consoli, Maria de Fátima Monteiro Martins, Flávio Cesar Viani, and Eduardo Fernandes Bondan, “Astrocytic expression of GFAP and serum levels of IL-1β and TNF-α in rats treated with different pain relievers,” Brazilian Journal of Pharmaceutical Sciences, vol. 52, no. 4, pp. 623–633, 2016. View at Publisher · View at Google Scholar
  • Zankhana Mehta, and Mellar P. Davis, “Opioids and Chronic Pain: Where Is the Balance?,” Current Oncology Reports, vol. 18, no. 12, 2016. View at Publisher · View at Google Scholar
  • Hillary H. Doyle, and Anne Z. Murphy, “Sex differences in innate immunity and its impact on opioid pharmacology,” Journal of Neuroscience Research, vol. 95, no. 1-2, pp. 487–499, 2016. View at Publisher · View at Google Scholar
  • Navid Feizy, Alireza Nourazarian, Reza Rahbarghazi, Hojjatollah Nozad Charoudeh, Nima Abdyazdani, Soheila Montazersaheb, and Mohamadreza Narimani, “Morphine Inhibited the Rat Neural Stem Cell Proliferation Rate by Increasing Neuro Steroid Genesis,” Neurochemical Research, 2016. View at Publisher · View at Google Scholar
  • Amy W. Voigt, and Harry J. Gould, “Chronic Daily Headache: Mechanisms and Principles of Management,” Current Pain and Headache Reports, vol. 20, no. 2, 2016. View at Publisher · View at Google Scholar
  • Shaifali Bhalla, Shridhar V. Andurkar, and Anil Gulati, “Neurobiology of opioid withdrawal: Role of the endothelin system,” Life Sciences, 2016. View at Publisher · View at Google Scholar
  • Chang Hyung Lee, Young Cheol Park, Jae Hwan Kim, Woon Young Kim, Yoon Sook Lee, Yun Hee Kim, and Too Jae Min, “The effects of hydromorphone on astrocytic responses in cerebral ischemia,” Anesthesia and Pain Medicine, vol. 11, no. 1, pp. 23–27, 2016. View at Publisher · View at Google Scholar
  • Ruben Vardanyan, and Victor Hruby, “Analgesics,” Synthesis of Best-Seller Drugs, pp. 15–64, 2016. View at Publisher · View at Google Scholar
  • Lir-Wan Fan, and Lu-Tai Tien, “Prenatal Methadone and Behavioral Sensitization Induced by Methamphetamine,” Neuropathology of Drug Addictions and Substance Misuse, pp. 589–594, 2016. View at Publisher · View at Google Scholar
  • Heath B. McAnally, and Heath B. McAnally, “Understanding the Agent, Part I: Opioid Biology and Basic Pharmacology,” Opioid Dependence, pp. 23–47, 2017. View at Publisher · View at Google Scholar
  • Heath B. McAnally, and Heath B. McAnally, “Attenuating the Agent: Reducing Opioid “Virulence”,” Opioid Dependence, pp. 99–118, 2017. View at Publisher · View at Google Scholar
  • Z.D. Cooper, K.W. Johnson, S.K. Vosburg, M.A. Sullivan, J. Manubay, D. Martinez, J.D. Jones, P.A. Saccone, and S.D. Comer, “Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers,” Drug and Alcohol Dependence, vol. 178, pp. 340–347, 2017. View at Publisher · View at Google Scholar
  • Reza Arezoomandan, Esmail Riahi, and Abbas Haghparast, “Minocycline increases firing rates of accumbal neurons and modifies the effects of morphine on neuronal activity,” Addiction Biology, 2017. View at Publisher · View at Google Scholar
  • Giulia Donvito, Sara R Nass, Jenny L Wilkerson, Zachary A Curry, Lesley D Schurman, Steven G Kinsey, and Aron H Lichtman, “The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain,” Neuropsychopharmacology, 2017. View at Publisher · View at Google Scholar
  • Jia-Xin Chen, Kang-Mei Huang, Meng Liu, Jin-Xiang Jiang, Jian-Peng Liu, Yu-Xiang Zhang, Chen-Yang, Wen-Jun Xin, and Xue-Qin Zhang, “Activation of TLR4/STAT3 signaling in VTA contributes to the acquisition and maintenance of morphine-induced conditioned place preference,” Behavioural Brain Research, 2017. View at Publisher · View at Google Scholar
  • Jorge Montesinos, Anabel Gil, and Consuelo Guerri, “Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4,” Alcoholism: Clinical and Experimental Research, 2017. View at Publisher · View at Google Scholar
  • Sukhada Bhave, Aravind Gade, Minho Kang, Kurt F. Hauser, William L. Dewey, and Hamid I. Akbarali, “Connexin-purinergic signaling in enteric glia mediates the prolonged effect of morphine on constipation,” FASEB Journal, vol. 31, no. 6, pp. 2649–2660, 2017. View at Publisher · View at Google Scholar
  • Verena E Metz, Jermaine D Jones, Jeanne Manubay, Maria A Sullivan, Shanthi Mogali, Andrew Segoshi, Gabriela Madera, Kirk W Johnson, and Sandra D Comer, “Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence,” Neuropsychopharmacology, 2017. View at Publisher · View at Google Scholar
  • Xue-Ting Deng, Yuan Han, Wen-Tao Liu, and Xue-Jun Song, “B Vitamins Potentiate Acute Morphine Antinociception and Attenuate the Development of Tolerance to Chronic Morphine in Mice,” Pain Medicine, 2017. View at Publisher · View at Google Scholar
  • Minho Kang, Ryan A. Mischel, Sukhada Bhave, Essie Komla, Alvin Cho, Charity Huang, William L. Dewey, and Hamid I. Akbarali, “The effect of gut microbiome on tolerance to morphine mediated antinociception in mice,” Scientific Reports, vol. 7, pp. 42658, 2017. View at Publisher · View at Google Scholar
  • H.H. Doyle, and A.Z. Murphy, “Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat,” Physiology & Behavior, 2017. View at Publisher · View at Google Scholar
  • Ryan K. Bachtell, Jermaine D. Jones, Keith G. Heinzerling, Patrick M. Beardsley, and Sandra D. Comer, “Glial and neuroinflammatory targets for treating substance use disorders,” Drug and Alcohol Dependence, vol. 180, pp. 156–170, 2017. View at Publisher · View at Google Scholar
  • Huy Tran, Mihir Gupta, and Kalpna Gupta, “Targeting novel mechanisms of pain in sickle cell disease,” Blood, vol. 130, no. 22, pp. 2377–2385, 2017. View at Publisher · View at Google Scholar
  • Sylvain Auvity, Sébastien Goutal, Benoît Thézé, Catarina Chaves, Benoît Hosten, Bertrand Kuhnast, Wadad Saba, Raphaël Boisgard, Irène Buvat, Salvatore Cisternino, and Nicolas Tournier, “Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal,” Drug and Alcohol Dependence, vol. 170, pp. 43–50, 2017. View at Publisher · View at Google Scholar
  • L. Perez-Caballero, M.L. Soto-Montenegro, M. Hidalgo-Figueroa, J.A. Mico, M. Desco, and E. Berrocoso, “Deep brain stimulation electrode insertion and depression: Patterns of activity and modulation by analgesics,” Brain Stimulation, 2018. View at Publisher · View at Google Scholar
  • Dayna L. Averitt, Lori N. Eidson, Hillary H. Doyle, and Anne Z. Murphy, “Neuronal and glial factors contributing to sex differences in opioid modulation of pain,” Neuropsychopharmacology, 2018. View at Publisher · View at Google Scholar
  • Matthew S. Karafin, Arun Singavi, Jawad Hussain, Nancy Wandersee, Thomas Heinrich, Robert W. Hurley, Liyun Zhang, Pippa Simpson, and Joshua J. Field, “Predictive factors of daily opioid use and quality of life in adults with sickle cell disease,” Hematology, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  • Vaskar Das, Ranjan Kc, Xin Li, Disha Varma, Sujun Qiu, Jeffrey S. Kroin, Christopher B. Forsyth, Ali Keshavarzian, Andre J. van Wijnen, Thomas J. Park, Gary S. Stein, Insug O-Sullivan, Thomas P. Burris, and Hee-Jeong Im, “Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain,” Gene, vol. 655, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Azadeh Elahi-Mahani, Soomaayeh Heysieattalab, Narges Hosseinmardi, Mahyar Janahmadi, Fatemeh Sadat Seyedaghamiri, and Habibeh Khoshbouei, “Glial Cells Modulate Hippocampal Synaptic Plasticity in Morphine Dependent Rats,” Brain Research Bulletin, 2018. View at Publisher · View at Google Scholar
  • Patrick Grenier, David Wiercigroch, Mary C. Olmstead, and Catherine M. Cahill, “Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists,” Behavioural Pharmacology, vol. 29, pp. 241–254, 2018. View at Publisher · View at Google Scholar
  • H. Harkouk, F. Pares, K. Daoudi, and D. Fletcher, “Farmacologia degli oppioidi,” EMC - Anestesia-Rianimazione, vol. 23, no. 2, pp. 1–22, 2018. View at Publisher · View at Google Scholar
  • Fatemehsadat Seyedaghamiri, Soomaayeh Heysieattalab, Narges Hosseinmardi, Mahyar Janahmadi, Azadeh Elahi-Mahani, Farhad Salari, Mehdi Golpayegani, and Habibeh Khoshbouei, “Hippocampal glial cells modulate morphine-induced behavioral responses,” Physiology & Behavior, 2018. View at Publisher · View at Google Scholar
  • H. Harkouk, F. Pares, K. Daoudi, and D. Fletcher, “Farmacología de los opioides,” EMC - Anestesia-Reanimación, vol. 44, no. 2, pp. 1–24, 2018. View at Publisher · View at Google Scholar
  • Jiali Shao, Jian Wang, Jiangju Huang, Chang Liu, Yundan Pan, Qulian Guo, and Wangyuan Zou, “Identification of lncRNA expression profiles and ceRNA analysis in the spinal cord of morphine-tolerant rats,” Molecular Brain, vol. 11, no. 1, 2018. View at Publisher · View at Google Scholar
  • Lu Chang, Fang Ye, Quehua Luo, Yuanxiang Tao, and Haihua Shu, “Increased Hyperalgesia and Proinflammatory Cytokines in the Spinal Cord and Dorsal Root Ganglion After Surgery and/or Fentanyl Administration in Rats,” Anesthesia & Analgesia, vol. 126, no. 1, pp. 289–297, 2018. View at Publisher · View at Google Scholar
  • 冬梅 张, “Investigation and Analysis of Drug Use in Elderly Patients with Medication Overuse Headache,” Advances in Clinical Medicine, vol. 08, no. 04, pp. 416–420, 2018. View at Publisher · View at Google Scholar
  • Launette Marie Rieb, Wendy V. Norman, Ruth Elwood Martin, Jonathan Berkowitz, Evan Wood, Michael John Milloy, and Ryan McNeil, “Linking opioid-induced hyperalgesia and withdrawal-associated injury site pain,” PAIN Reports, vol. 3, no. 3, pp. e648, 2018. View at Publisher · View at Google Scholar
  • Leonard B. Kamen, “Central Sensitization, Central Sensitization Syndromes, and Chronic Neuropathic Pain,” Challenging Neuropathic Pain Syndromes, pp. 7–20, 2018. View at Publisher · View at Google Scholar